Psychological therapies for sickle cell disease and pain

被引:46
|
作者
Anie, Kofi A. [1 ]
Green, John [2 ]
机构
[1] London North West Healthcare NHS Trust, Haematol & Sickle Cell Ctr, London, England
[2] St Marys Hosp, Dept Clin Hlth Psychol, London, England
来源
COCHRANE DATABASE OF SYSTEMATIC REVIEWS | 2015年 / 05期
关键词
*Adaptation; Psychological; Depression [psychology; therapy; Hemoglobin SC Disease [*therapy; Outcome Assessment ( Health Care); Pain [psychology; Pain Management [*methods; Psychotherapy [*methods; Randomized Controlled Trials as Topic; Adolescent; Adult; Child; Humans; HEMOGLOBIN; ADOLESCENTS; HYDROXYUREA; MANAGEMENT; CHILDREN; TRENDS; ADULTS;
D O I
10.1002/14651858.CD001916.pub3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Sickle cell disease comprises a group of genetic blood disorders. It occurs when the sickle haemoglobin gene is inherited from both parents. The effects of the condition are: varying degrees of anaemia which, if severe, can reduce mobility; a tendency for small blood capillaries to become blocked causing pain in muscle and bone commonly known as 'crises'; damage to major organs such as the spleen, liver, kidneys, and lungs; and increased vulnerability to severe infections. There are both medical and non-medical complications, and treatment is usually symptomatic and palliative in nature. Psychological interventions for individuals with sickle cell disease might complement current medical treatment, and studies of their efficacy have yielded encouraging results. This is an update of a previously published Cochrane Review. Objectives To examine the evidence that psychological interventions improve the ability of people with sickle cell disease to cope with their condition. Search methods We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group Haemoglobinopathies Trials Register, which comprises references identified from comprehensive electronic database searches and the Internet, handsearches of relevant journals and abstract books of conference proceedings. Date of the most recent search of the Group's Haemoglobinopathies Trials Register: 17 February 2015. Selection criteria All randomised or quasi-randomised controlled trials comparing psychological interventions with no (psychological) intervention in people with sickle cell disease. Data collection and analysis Both authors independently extracted data and assessed the risk of bias of the included studies. Main results Twelve studies were identified in the searches and seven of these were eligible for inclusion in the review. Five studies, involving 260 participants, provided data for analysis. One study showed that cognitive behaviour therapy significantly reduced the affective component of pain (feelings about pain), mean difference -0.99 (95% confidence interval -1.62 to -0.36), but not the sensory component (pain intensity), mean difference 0.00 (95% confidence interval -9.39 to 9.39). One study of family psycho-education was not associated with a reduction in depression. Another study evaluating cognitive behavioural therapy had inconclusive results for the assessment of coping strategies, and showed no difference between groups assessed on health service utilisation. In addition, family home-based cognitive behavioural therapy did not show any difference compared to disease education. One study of patient education on health beliefs showed a significant improvement in attitudes towards health workers, mean difference -4.39 (95% CI -6.45 to -2.33) and medication, mean difference -1.74 (95% CI -2.98 to -0.50). Nonetheless, these results may not apply across all ages, severity of sickle cell disease, types of pain (acute or chronic), or setting. Authors' conclusions Evidence for the efficacy of psychological therapies in sickle cell disease is currently limited. This systematic review has clearly identified the need for well-designed, adequately-powered, multicentre randomised controlled trials assessing the effectiveness of specific interventions in sickle cell disease.
引用
收藏
页数:33
相关论文
共 50 条
  • [1] Psychological therapies for sickle cell disease and pain
    Anie, Kofi A.
    Green, John
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (02):
  • [2] Pain in sickle cell disease: current and potential translational therapies
    Sagia, Varun
    Mittala, Aditya
    Tran, Huy
    Gupta, Kalpna
    TRANSLATIONAL RESEARCH, 2021, 234 : 141 - 158
  • [3] Neurocognitive and psychological effects of persistent pain in pediatric sickle cell disease
    Connolly, Megan E.
    Bills, Sarah E.
    Hardy, Steven J.
    PEDIATRIC BLOOD & CANCER, 2019, 66 (09)
  • [4] Gout and sickle cell disease: not all pain is sickle cell pain
    Gupta, Sarthak
    Yui, Jennifer C.
    Xu, Dihua
    Fitzhugh, Courtney D.
    Clark, Caroline
    Siddiqui, Salahuddin
    Conrey, Anna K.
    Kato, Gregory J.
    Minniti, Caterina P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (05) : 872 - 875
  • [5] New therapies in sickle cell disease
    Dimopoulou, Maria M.
    LEUKEMIA RESEARCH, 2018, 73 : S14 - S15
  • [6] Genetic Therapies for Sickle Cell Disease
    Jayavaradhan, Rajeswari
    Malik, Punam
    PEDIATRIC CLINICS OF NORTH AMERICA, 2018, 65 (03) : 465 - +
  • [7] Emerging therapies in sickle cell disease
    Nardo-Marino, Amina
    Brousse, Valentine
    Rees, David
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (02) : 149 - 172
  • [8] Genetic therapies for sickle cell disease
    Esrick, Erica B.
    Bauer, Daniel E.
    SEMINARS IN HEMATOLOGY, 2018, 55 (02) : 76 - 86
  • [9] Curative Therapies for Sickle Cell Disease
    Khemani, Kirshma
    Katoch, Deeksha
    Krishnamurti, Lakshmanan
    OCHSNER JOURNAL, 2019, 19 (02): : 131 - 137
  • [10] Gene Therapies for Sickle Cell Disease
    Weaver, Salome Bwayo
    Singh, Divita
    Wilson, Kierra M.
    JOURNAL OF PHARMACY TECHNOLOGY, 2024, 40 (05) : 236 - 247